Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-25 @ 9:34 PM
Study NCT ID:
NCT01027351
Status:
COMPLETED
Last Update Posted:
2018-10-09
First Post:
2009-12-04
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine
Sponsor:
Novartis Vaccines
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-01
Start Date Type:
None
Primary Completion Date:
2010-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05
Completion Date Type:
ACTUAL
First Submit Date:
2009-12-04
First Submit QC Date:
None
Study First Post Date:
2009-12-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-12-18
Results First Submit QC Date:
None
Results First Post Date:
2014-05-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-10
Last Update Post Date:
2018-10-09
Last Update Post Date Type:
ACTUAL